Suppr超能文献

心肌细胞中α1-肾上腺素能刺激对S100B基因的调控。

Regulation of the S100B gene by alpha 1-adrenergic stimulation in cardiac myocytes.

作者信息

Tsoporis James N, Marks Alexander, Van Eldik Linda J, O'Hanlon David, Parker Thomas G

机构信息

Division of Cardiology, Department of Medicine, The Toronto General Hospital Research Institute, University of Toronto, Ontario M5G 1L6, Canada.

出版信息

Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H193-203. doi: 10.1152/ajpheart.00161.2002. Epub 2002 Sep 5.

Abstract

We previously reported that S100B, a 20-kDa Ca(2+)-binding homodimer, inhibited the postinfarct myocardial hypertrophic response mediated by alpha(1)-adrenergic stimulation through the protein kinase C (PKC) signaling pathway. In the present study, we examined whether the same pathway induced the S100B gene, supporting the hypothesis that S100B is a feedback negative regulator of this pathway. We transfected cultured neonatal rat cardiac myocytes with a luciferase reporter gene driven by the maximal human S100B promoter and progressively shorter segments of this promoter sequentially deleted from the 5' end. We identified a basic promoter essential for transcription spanning 162 bp upstream of the transcription initiation site and positive (at -782/-162 and -6,689/-4,463) and negative (at -4,463/-782) myocyte-selective regulatory elements. We showed that the basic and maximal S100B promoters were activated specifically by alpha(1)-adrenergic agonists through the alpha(1A)-adrenergic receptor, but not by any other trophic hormonal stimuli. The activation of the S100B promoter was mediated through the PKC signaling pathway. Transcription enhancer factor-1 (TEF-1) and related to TEF-1 (RTEF-1) influenced transcription from the maximal, but not the basic, promoter implicating active MCAT elements upstream from the basic promoter. Acting in opposing fashions, TEF-1 transrepressed the S100B promoter and RTEF-1 transactivated the promoter. Our results suggest that alpha(1)-adrenergic stimulation induces the S100B gene after myocardial infarction through the PKC signaling pathway and that this induction is modulated by TEF-1 and RTEF-1.

摘要

我们之前报道过,S100B是一种20 kDa的钙结合同型二聚体,它通过蛋白激酶C(PKC)信号通路抑制由α1 -肾上腺素能刺激介导的梗死后心肌肥厚反应。在本研究中,我们检测了同一信号通路是否能诱导S100B基因,以支持S100B是该信号通路的反馈负调节因子这一假说。我们用由人S100B最大启动子驱动的荧光素酶报告基因以及从5'端依次缺失该启动子的逐渐缩短片段转染培养的新生大鼠心肌细胞。我们确定了一个对转录至关重要的基本启动子,其跨度为转录起始位点上游162 bp,以及正向(位于 -782/-162和 -6,689/-4,463)和负向(位于 -4,463/-782)的心肌细胞选择性调节元件。我们发现基本和最大的S100B启动子通过α1A -肾上腺素能受体被α1 -肾上腺素能激动剂特异性激活,但不被任何其他营养激素刺激激活。S100B启动子的激活是通过PKC信号通路介导的。转录增强因子 -1(TEF -1)和与TEF -1相关的因子(RTEF -1)影响最大启动子而非基本启动子的转录,这表明基本启动子上游存在活跃的MCAT元件。TEF -1和RTEF -1以相反的方式起作用,TEF -1反式抑制S100B启动子,而RTEF -1反式激活该启动子。我们的结果表明,α1 -肾上腺素能刺激在心肌梗死后通过PKC信号通路诱导S100B基因,并且这种诱导受到TEF -1和RTEF -1的调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验